Our data first suggest that LRSAM1 promotes the oncogenic growth of human HCC cells, and knock down of LRSAM1 suppresses the malignant growth of HCC xenograft in nude mice. The gene discussed is LRSAM1; the disease is hepatocellular carcinoma.